Review of nano-based devices planned by EU committee

04/2/2012 | Clinica (subscription required)

The European Commission's Scientific Committee on Emerging and Newly Identified Health Risks has been asked to perform a risk evaluation of medical devices that use nanomaterials and submit feedback by next March. The commission will use the feedback to help craft proposals on labeling, risk categorization and instructions for these devices.

View Full Article in:

Clinica (subscription required)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA